Your search returned 64 results.

Results
	1.	First bacterial infection as an alternative clinical end point for regulatory approval of agents targeting the primary cystic fibrosis defect. [electronic resource] by VanDevanter, Donald R Producer: 20051110 In: The Journal of pediatrics vol. 147 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Tobramycin administered by the TOBI(®) Podhaler(®) for persons with cystic fibrosis: a review. [electronic resource] by Vandevanter, Donald R Geller, David E Producer: 20121002 In: Medical devices (Auckland, N.Z.) vol. 4 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Clinical applications of pulmonary delivery of antibiotics. [electronic resource] by Flume, Patrick A VanDevanter, Donald R Producer: 20160224 In: Advanced drug delivery reviews vol. 85 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	The Cystic Fibrosis Survival Gap: Why Do Canadians Fare Better Than Americans? [electronic resource] by Flume, Patrick A VanDevanter, Donald R Producer: 20171208 In: Annals of internal medicine vol. 166 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	The challenge of improving outcomes for patients with CF sinonasal disease. [electronic resource] by VanDevanter, Donald R Southern, Kevin W Producer: 20150212 In: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society vol. 13 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Outcome measures for clinical trials assessing treatment of cystic fibrosis lung disease. [electronic resource] by VanDevanter, Donald R Konstan, Michael W Publication details: Clinical investigation In: Clinical investigation vol. 2 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	CFTR modulators and pregnancy: Our work has only just begun. [electronic resource] by Goss, Christopher H VanDevanter, Donald R Producer: 20160824 In: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society vol. 15 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Leveraging early markers of cystic fibrosis structural lung disease to improve outcomes. [electronic resource] by Flume, Patrick A VanDevanter, Donald R Producer: 20201019 In: The European respiratory journal vol. 55 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Evidence of diminished FEV1 and FVC in 6-year-olds followed in the European Cystic Fibrosis Patient Registry, 2007-2009. [electronic resource] by VanDevanter, Donald R Pasta, David J Producer: 20140929 In: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	Innovating cystic fibrosis clinical trial designs in an era of successful standard of care therapies. [electronic resource] by VanDevanter, Donald R Mayer-Hamblett, Nicole Producer: 20180427 In: Current opinion in pulmonary medicine vol. 23 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	11.	The challenges of maintaining momentum in CF drug development and approval - Commentary. [electronic resource] by Flume, Patrick A VanDevanter, Donald R Producer: 20190415 In: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society vol. 16 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	12.	Microbial diversity in the cystic fibrosis airways: where is thy sting? [electronic resource] by VanDevanter, Donald R LiPuma, John J Producer: 20140828 In: Future microbiology vol. 7 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	13.	Efficacy measures for clinical trials: A review series. [electronic resource] by Flume, Patrick A VanDevanter, Donald R Producer: 20180727 In: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society vol. 15 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	14.	How much do Pseudomonas biofilms contribute to symptoms of pulmonary exacerbation in cystic fibrosis? [electronic resource] by VanDevanter, Donald R Van Dalfsen, Jill M Producer: 20051026 In: Pediatric pulmonology vol. 39 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	15.	Applying clinical outcome variables to appropriate aerosolized antibiotics for the treatment of patients with cystic fibrosis. [electronic resource] by VanDevanter, Donald R Ballmann, Manfred Flume, Patrick A Producer: 20120301 In: Respiratory medicine vol. 105 Suppl 2 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	16.	Feasibility of placebo-controlled trial designs for new CFTR modulator evaluation. [electronic resource] by VanDevanter, Donald R Mayer-Hamblett, Nicole Boyle, Michael Producer: 20180426 In: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society vol. 16 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	17.	Aerosolized antibiotic therapy for chronic cystic fibrosis airway infections: continuous or intermittent? [electronic resource] by Lo, David VanDevanter, Donald R Flume, Patrick Smyth, Alan Producer: 20120301 In: Respiratory medicine vol. 105 Suppl 2 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	18.	Association between the introduction of a new cystic fibrosis inhaled antibiotic class and change in prevalence of patients receiving multiple inhaled antibiotic classes. [electronic resource] by Dasenbrook, Elliott C Konstan, Michael W VanDevanter, Donald R Producer: 20160126 In: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	19.	IV-treated pulmonary exacerbations in the prior year: An important independent risk factor for future pulmonary exacerbation in cystic fibrosis. [electronic resource] by VanDevanter, Donald R Morris, Nathan J Konstan, Michael W Producer: 20171218 In: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society vol. 15 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	20.	Characterizing aggressiveness and predicting future progression of CF lung disease. [electronic resource] by Konstan, Michael W Wagener, Jeffrey S VanDevanter, Donald R Producer: 20090803 In: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society vol. 8 Suppl 1 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

1
2
3
4
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 64 results.